# Chase Pharmaceuticals Corp — Form D

Chase Pharmaceuticals Corp of WASHINGTON, DC, a company, filed a Form D exempt-offering notice with the SEC on 2015-08-20. The offering totals $3.0M, of which $3.0M was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2015-08-20
- Form: D
- Accession: 0001140361-15-032968
- Industry: Pharmaceuticals
- Exemptions: 06b
- Total offering: $3.0M
- Amount sold: $3.0M
- Investors: 12
- Date of first sale: 2015-08-05
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-246193

## Issuer

- Name: Chase Pharmaceuticals Corp
- CIK: 0001509008
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2007
- Address: 1825 K Street, NW, WASHINGTON, DC, 20006
- Phone: 202-792-4621

## Officers, directors & promoters (22)

| Name | Role | Location |
| --- | --- | --- |
| N. Greg Parekh | Director | Washington, DC |
| John M Siebert | Executive Officer | Hayward, CA |
| Richard P Dulik | Executive Officer | Washington, DC |
| Kathleen N Clarence-Smith | Executive Officer | Washington, DC |
| Thomas N Chase | Director | Washington, DC |
| Thomas N Chase | Executive Officer | Washington, DC |
| John M Siebert | Director | Hayward, CA |
| Vikram M Sudarsan | Director | Washington, DC |
| Raphael M Wisniewski | Director | Washington, DC |
| Stephen N Cunningham | Director | Washington, DC |
| Nayan Greg Parekh | Director | Washington, DC |
| Karoly N Nikolich | Director | Washington, DC |
| Douglas Ingram | Director | Washington, DC, DC |
| Douglas Ingram | Executive Officer | Washington, DC, DC |
| Raphael N Wisniewski | Director | Washington, DC |
| Greg N Parekh | Director | Washington, DC |
| Vikram N Sudarsan | Director | Washington, DC |
| John M Reher | Director | Burlingame, CA |
| John M Reher | Executive Officer | Burlingame, CA |
| Kathleen P Clarence-Smith | Director | Washington, DC |
| Kathleen P Clarence-Smith | Executive Officer | Washington, DC |
| Karoly M Nikolich | Director | Burlingame, CA |

## Other filings by this issuer (6)

| Filed | Form | Offering | Sold |
| --- | --- | --- | --- |
| [2016-03-28](https://search.stillhousedata.com/formd/0001140361-16-059094) | D | $12.0M | $12.0M |
| [2016-02-17](https://search.stillhousedata.com/formd/0001140361-16-053439) | D/A | $3.5M | $3.5M |
| [2016-02-17](https://search.stillhousedata.com/formd/0001140361-16-053437) | D | $107K | — |
| [2016-02-16](https://search.stillhousedata.com/formd/0001140361-16-053435) | D | $613K | — |
| [2014-05-30](https://search.stillhousedata.com/formd/0001509008-14-000001) | D | $8.6M | $6.1M |
| [2011-01-05](https://search.stillhousedata.com/formd/0001509008-11-000001) | D | $1.2M | $1.2M |

## More

- [CIK 1509008 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1509008&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001140361-15-032968.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.